COMP <GO>
CHKP vs MANH // 10Y YIELD & FRED MACRO BETA
Check Point Software Technologies Ltd. (NASDAQ) VS. Manhattan Associates Inc. (NASDAQ) • 15-METRIC TALLY: CHKP 10
— MANH 3
▲ 10Y YIELD & FRED MACRO BETA LEADER: MANH
LAST: $141.50 (-6.97%) • MKT CAP: $15.53B
macro-sensitivity
1.38
LAST: $253.22 (+1.95%) • MKT CAP: $14.48B
macro-sensitivity
1.42
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHKP VS. MANH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHKP | MANH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.70% | 56.30% | +30.40 | CHKP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.80% | 19.70% | +1.10 | CHKP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.7x | 47.4x | -28.70 | CHKP | /valuation <GO> |
| Free Cash Flow Yield | 7.48% | 2.66% | +4.82 | CHKP | /fcf-yield <GO> |
| Operating Margin | 30.50% | 25.90% | +4.60 | CHKP | /operating-margins <GO> |
| Net Profit Margin | 38.80% | 20.30% | +18.50 | CHKP | /net-margins <GO> |
| Revenue Growth (YoY) | 6.30% | 3.70% | +2.60 | CHKP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.62 | 24.06 | -18.44 | MANH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | CHKP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.4 | 67.8 | -6.40 | MANH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.38 | 1.42 | -0.04 | MANH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.8x | 59.3x | -45.50 | CHKP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.53B | $14.48B | $1.05B | CHKP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHKP REV | MANH REV | CHKP GROSS % | MANH GROSS % | CHKP FCF | MANH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $1.08B | 86.7% | 56.3% | $1.17B | $374.0M |
| FY 2024 | $2.56B | $1.04B | 87.6% | 54.8% | $1.03B | $286.3M |
| FY 2023 | $2.41B | $928.7M | — | — | $929.2M | $204.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHKP // BETA 1.38
MANH // BETA 1.42